Search Results

There are 1831 results for: content related to: Reduced numbers of circulating CD 28-negative CD 4+ cells in patients with rheumatoid arthritis chronically treated with abatacept

  1. Abatacept for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Lara Maxwell and Jasvinder A Singh

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD007277.pub2

  2. You have full text access to this OnlineOpen article
    Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate

    Arthritis & Rheumatism

    Volume 63, Issue 10, October 2011, Pages: 2854–2864, M. C. Genovese, A. Covarrubias, G. Leon, E. Mysler, M. Keiserman, R. Valente, P. Nash, J. A. Simon-Campos, W. Porawska, J. Box, C. Legerton III, E. Nasonov, P. Durez, R. Aranda, R. Pappu, I. Delaet, J. Teng and R. Alten

    Version of Record online : 27 SEP 2011, DOI: 10.1002/art.30463

  3. The clinical utility of inhibiting CD28-mediated costimulation

    Immunological Reviews

    Volume 229, Issue 1, May 2009, Pages: 307–321, Peter S. Linsley and Steven G. Nadler

    Version of Record online : 21 APR 2009, DOI: 10.1111/j.1600-065X.2009.00780.x

  4. Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study

    International Journal of Rheumatic Diseases

    Tristan Pascart, Peggy Philippe, Elodie Drumez, Xavier Deprez, Bernard Cortet, Alain Duhamel, Eric Houvenagel and René-Marc Flipo

    Version of Record online : 27 MAR 2016, DOI: 10.1111/1756-185X.12845

  5. You have free access to this content
    Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study

    Arthritis & Rheumatism

    Volume 54, Issue 9, September 2006, Pages: 2807–2816, M. Weinblatt, B. Combe, A. Covucci, R. Aranda, J. C. Becker and E. Keystone

    Version of Record online : 31 AUG 2006, DOI: 10.1002/art.22070

  6. Abatacept in the treatment of rheumatoid arthritis

    International Journal of Clinical Practice

    Volume 61, Issue 3, March 2007, Pages: 494–500, D. J. Todd, K. H. Costenbader and M. E. Weinblatt

    Version of Record online : 14 FEB 2007, DOI: 10.1111/j.1742-1241.2007.01289.x

  7. Abatacept Inhibition of T Cell Priming in Mice by Induction of a Unique Transcriptional Profile That Reduces Their Ability to Activate Antigen-Presenting Cells

    Arthritis & Rheumatology

    Volume 68, Issue 3, March 2016, Pages: 627–638, Agapitos Patakas, Rui-Ru Ji, William Weir, Sean E. Connolly, Robert A. Benson, Steven G. Nadler, James M. Brewer, Iain B. McInnes and Paul Garside

    Version of Record online : 24 FEB 2016, DOI: 10.1002/art.39470

  8. You have free access to this content
    Abatacept, a Novel CD80/86–CD28 T Cell Co-stimulation Modulator, in the Treatment of Rheumatoid Arthritis

    Basic & Clinical Pharmacology & Toxicology

    Volume 104, Issue 4, April 2009, Pages: 276–284, Riku Korhonen and Eeva Moilanen

    Version of Record online : 18 FEB 2009, DOI: 10.1111/j.1742-7843.2009.00375.x

  9. You have full text access to this OnlineOpen article
    Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years

    Arthritis & Rheumatology

    Volume 67, Issue 10, October 2015, Pages: 2759–2770, Daniel J. Lovell, Nicolino Ruperto, Richard Mouy, Eliana Paz, Nadina Rubio-Pérez, Clovis A. Silva, Carlos Abud-Mendoza, Ruben Burgos-Vargas, Valeria Gerloni, Jose A. Melo-Gomes, Claudia Saad-Magalhaes, J. Chavez-Corrales, Christian Huemer, Alan Kivitz, Francisco J. Blanco, Ivan Foeldvari, Michael Hofer, Hans-Iko Huppertz, Chantal Job Deslandre, Kirsten Minden, Marilynn Punaro, Alan J. Block, Edward H. Giannini, Alberto Martini and for the Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation

    Version of Record online : 23 SEP 2015, DOI: 10.1002/art.39234

  10. You have free access to this content
    Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 52, Issue 8, August 2005, Pages: 2263–2271, Joel M. Kremer, Maxime Dougados, Paul Emery, Patrick Durez, Jean Sibilia, William Shergy, Serge Steinfeld, Elizabeth Tindall, Jean-Claude Becker, Tracy Li, Isaac F. Nuamah, Richard Aranda and Larry W. Moreland

    Version of Record online : 28 JUL 2005, DOI: 10.1002/art.21201

  11. Adverse effects of biologics: a network meta-analysis and Cochrane overview

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, George A Wells, Robin Christensen, Elizabeth Tanjong Ghogomu, Lara J Maxwell, John K MacDonald, Graziella Filippini, Nicole Skoetz, Damian K Francis, Luciane C Lopes, Gordon H Guyatt, Jochen Schmitt, Loredana La Mantia, Tobias Weberschock, Juliana F Roos, Hendrik Siebert, Sarah Hershan, Chris Cameron, Michael PT Lunn, Peter Tugwell and Rachelle Buchbinder

    Published Online : 16 FEB 2011, DOI: 10.1002/14651858.CD008794.pub2

  12. Modeling and Simulation of Abatacept Exposure and Interleukin-6 Response in Support of Recommended Doses for Rheumatoid Arthritis

    The Journal of Clinical Pharmacology

    Volume 47, Issue 11, November 2007, Pages: 1408–1420, Dr Amit Roy, Dr Diane R. Mould, Dr Xiao-Feng Wang, Dr Lee Tay, Mr Ralph Raymond and Dr Marc Pfister

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007307573

  13. You have free access to this content
    Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate

    Arthritis & Rheumatism

    Volume 58, Issue 4, April 2008, Pages: 953–963, Joel M. Kremer, Harry K. Genant, Larry W. Moreland, Anthony S. Russell, Paul Emery, Carlos Abud-Mendoza, Jacek Szechiński, Tracy Li, Julie Teng, Jean-Claude Becker and René Westhovens

    Version of Record online : 27 MAR 2008, DOI: 10.1002/art.23397

  14. You have full text access to this OnlineOpen article
    Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study

    Arthritis & Rheumatism

    Volume 65, Issue 1, January 2013, Pages: 28–38, Michael E. Weinblatt, Michael Schiff, Robert Valente, Désirée van der Heijde, Gustavo Citera, Cathy Zhao, Michael Maldonado and Roy Fleischmann

    Version of Record online : 27 DEC 2012, DOI: 10.1002/art.37711

  15. You have free access to this content
    Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel-Arm, Open-Label Study

    Arthritis Care & Research

    Volume 65, Issue 5, May 2013, Pages: 718–728, Peter Nash, Sauithree Nayiager, Mark C. Genovese, Alan J. Kivitz, Kurt Oelke, Charles Ludivico, William Palmer, Cristian Rodriguez, Ingrid Delaet, Ayanbola Elegbe and Michael Corbo

    Version of Record online : 23 APR 2013, DOI: 10.1002/acr.21876

  16. You have free access to this content
    The efficacy and safety of abatacept in patients with non–life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 62, Issue 10, October 2010, Pages: 3077–3087, J. T. Merrill, R. Burgos-Vargas, R. Westhovens, A. Chalmers, D. D'Cruz, D. J. Wallace, S. C. Bae, L. Sigal, J.-C. Becker, S. Kelly, K. Raghupathi, T. Li, Y. Peng, M. Kinaszczuk and P. Nash

    Version of Record online : 8 JUN 2010, DOI: 10.1002/art.27601

  17. You have full text access to this OnlineOpen article
    Long-Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment

    Arthritis & Rheumatology

    Volume 66, Issue 8, August 2014, Pages: 1987–1997, Rieke Alten, Jeffrey Kaine, Edward Keystone, Peter Nash, Ingrid Delaet and Mark C. Genovese

    Version of Record online : 28 JUL 2014, DOI: 10.1002/art.38687

  18. Biologics for rheumatoid arthritis: an overview of Cochrane reviews

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Robin Christensen, George A Wells, Maria E Suarez-Almazor, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Elizabeth Tanjong Ghogomu and Peter Tugwell

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD007848.pub2

  19. You have free access to this content
    Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis

    Arthritis & Rheumatism

    Volume 62, Issue 6, June 2010, Pages: 1792–1802, Nicolino Ruperto, Daniel J. Lovell, Pierre Quartier, Eliana Paz, Nadina Rubio-Pérez, Clovis A. Silva, Carlos Abud-Mendoza, Ruben Burgos-Vargas, Valeria Gerloni, Jose A. Melo-Gomes, Claudia Saad-Magalhães, J. Chavez-Corrales, Christian Huemer, Alan Kivitz, Francisco J. Blanco, Ivan Foeldvari, Michael Hofer, Gerd Horneff, Hans-Iko Huppertz, Chantal Job-Deslandre, Anna Loy, Kirsten Minden, Marilynn Punaro, Alejandro Flores Nunez, Leonard H. Sigal, Alan J. Block, Marleen Nys, Alberto Martini and Edward H. Giannini

    Version of Record online : 26 FEB 2010, DOI: 10.1002/art.27431

  20. You have full text access to this OnlineOpen article
    Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve-Month, Randomized, Double-Blind Study

    Arthritis & Rheumatology

    Volume 66, Issue 2, February 2014, Pages: 379–389, Richard Furie, Kathy Nicholls, Tien-Tsai Cheng, Frederic Houssiau, Ruben Burgos-Vargas, Shun-Le Chen, Jan L. Hillson, Stephanie Meadows-Shropshire, Michael Kinaszczuk and Joan T. Merrill

    Version of Record online : 27 JAN 2014, DOI: 10.1002/art.38260